Interesting facts
Interesting Facts About (2S)-2-[[4-[(2,4-diaminoquinazolin-6-yl)methylamino]benzoyl]amino]butanedioic acid
(2S)-2-[[4-[(2,4-diaminoquinazolin-6-yl)methylamino]benzoyl]amino]butanedioic acid is a fascinating compound often discussed in the fields of medicinal chemistry and pharmaceutical research. Its intricate structure is integral in the development of targeted therapies, particularly in the realm of cancer treatment. Here are some noteworthy points about this compound:
- Mechanistic Role: This compound functions as an important intermediate in the synthesis of various enzyme inhibitors that are crucial in anti-cancer drug development.
- Structural Features: The presence of a quinazoline ring and amino groups enhances its interaction with biological targets, allowing it to effectively bind to specific proteins involved in tumor growth.
- Targeted Therapy: Its design reflects a strategic approach in bioactive compound synthesis where precision is key, commonly used in the search for therapies that minimize side effects while maximizing therapeutic efficacy.
- Pharmaceutical Significance: As a member of a larger class of compounds, it shows promise in addressing resistance mechanisms often displayed by malignancies, thus paving the way for more effective cancer treatment protocols.
- Research Applications: This compound is frequently utilized in studies focusing on drug delivery systems, exploring its potential to improve therapeutic outcomes in various carcinomas.
Overall, the study of (2S)-2-[[4-[(2,4-diaminoquinazolin-6-yl)methylamino]benzoyl]amino]butanedioic acid embodies the complex interplay of chemical structure and biological function, showcasing the impact of organic chemistry in addressing some of the most pressing challenges in modern medicine.
Synonyms
Quinaspar
18921-65-8
NSC 112846
BRN 0904792
SK 29758
N-(p-(((2,4-Diamino-6-quinazolinyl)methyl)amino)benzoyl)-L-aspartic acid
L-Aspartic acid, N-(4-(((2,4-diamino-6-quinazolinyl)methyl)amino)benzoyl)-
ASPARTIC ACID, N-(p-(((2,4-DIAMINO-6-QUINAZOLINYL)METHYL)AMINO)BENZOYL)-, L-
L-Aspartic acid, N-(4-(((2,4-diamino-6-quinazolinyl)methyl)amino)benzoyl)-(9CI)
(2S)-2-[[4-[(2,4-diaminoquinazolin-6-yl)methylamino]benzoyl]amino]butanedioic acid
2-[[4-[(2,4-diaminoquinazolin-6-yl)methylamino]benzoyl]amino]butanedioic acid
CHEMBL3244847
SCHEMBL29286034
Solubility of (2S)-2-[[4-[(2,4-diaminoquinazolin-6-yl)methylamino]benzoyl]amino]butanedioic acid
The solubility of (2S)-2-[[4-[(2,4-diaminoquinazolin-6-yl)methylamino]benzoyl]amino]butanedioic acid is influenced by several factors, which are crucial for its application in various fields. Understanding its solubility characteristics can be key in processes ranging from pharmaceutical formulations to chemical reactions.
Factors Affecting Solubility:
In general, a few points about this compound's solubility include:
As described, the solubility of (2S)-2-[[4-[(2,4-diaminoquinazolin-6-yl)methylamino]benzoyl]amino]butanedioic acid is an important consideration for scientists, especially in determining effective concentrations for biological assays or drug formulation.